New Headquarters – PL BioScience Announces Major Site Expansion in September 2025
Key Milestone for PL BioScience as new headquarters are announced
PL BioScience announced the next major step in its expansion – an upcoming move to a new 1,200 m² facility in Aachen, in September 2025. This key milestone will support the company’s growth and upscaling efforts, and provide the world’s largest HPL output, with 20,000L annual capacity to meet the rapidly growing global demand for safe, high-quality, animal-free cell culture supplements.
The new headquarters includes dedicated production and storage areas, alongside office space to accommodate the company’s continued growth, positioning it as the largest provider of HPL products worldwide. It will also provide more highly skilled jobs in the region.
“This is a major step forward for PL BioScience,” said Dr. Hatim Hemeda, CEO of the German biotech. “With the new headquarters, we are accelerating our growth and strengthening our future production capabilities in response to growing global demand for HPL products. In addition, this expansion marks a significant step toward accelerating product innovation, including the further development of our new artificial HPL, the world’s first scalable, fully lab-made HPL solution.”
The facility will serve as a hub for research and product innovation, supporting the development of next-generation HPL-based media, such as artificial HPL. Other advanced products are in development, including specialized products tailored to the needs of different cell manufacturing applications, such as CAR-T cell manufacturing.
Read the full press release here.
